Clearmind Medicine Inc. Common Shares Stock Prediction
AI-powered sentiment analysis and prediction trends for CMND, updated each market day.
CMND AI Sentiment
AI predicts Clearmind Medicine Inc. Common Shares stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Clearmind Medicine Inc. Common Shares
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
Exchange
Market Cap
$2,888,945
Cap Tier
Employees
2
Listed Since
Aug. 10, 2021
CMND Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CMND Volatility
Clearmind Medicine Inc. Common Shares has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
